North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
The North American Endoscopic Retrograde Cholangiopancreatography (ERCP) market was valued at approximately USD 0.90 billion in 2023, with projections indicating steady growth at a 6% compound annual growth rate (CAGR) over the forecast period. This growth is driven by an increasing incidence of gastrointestinal cancers, significant investments in innovative ERCP technologies by hospitals and research centers, and ongoing efforts to enhance endoscopic procedures. North America's concentration of major industry players further emphasizes the market’s importance. According to the American Society of Clinical Oncology (ASCO), 31,950 men and 28,480 women in the U.S. were diagnosed with pancreatic cancer in 2021, accounting for roughly 3% of all cancer cases. Pancreatic cancer ranks as the eighth most common among women and tenth among men, with its incidence rising by approximately 1% annually over the last decade.
Market Dynamics
The market's expansion is fueled by the growing prevalence of pancreatic and biliary diseases, the presence of numerous key market players, and advancements in technology. However, the strict regulatory policies of the U.S. Food and Drug Administration (FDA) present challenges. On the positive side, the well-developed healthcare infrastructure and favorable reimbursement frameworks create opportunities for growth. With an increase in cases of biliary stones and pancreatic cancer, demand for ERCP procedures is expected to rise significantly throughout the forecast period. The American Cancer Society reported that pancreatic cancer accounted for 60,430 new cases and 48,220 deaths in 2021, ranking third after lung and colorectal cancers.
For comprehensive insights, visit: Explore the Study@https://www.stellarmr.com/report/req_sample/North-America-Endoscopic-Retrograde-Cholangiopancreatography-Market/709
A shortage of skilled professionals could impede market growth, as ERCP procedures require both a physician and a radiologist for successful execution. The radiologist plays a critical role in guiding the physician by identifying abnormalities in the pancreas, biliary ducts, and duodenum. The incidence of liver and intrahepatic bile duct cancer has also surged, with 41,260 new cases anticipated in the U.S. in 2022, reflecting a more than threefold increase over previous decades.
Segment Analysis
By Product Type:
Endotherapy devices are anticipated to lead the market by 2030, supported by the rising prevalence of gastrointestinal disorders and the increasing demand for minimally invasive surgeries. Substantial investments in healthcare infrastructure further boost the ERCP market in North America.
By End-User:
Hospitals and clinics dominate the market, driven by high procedure volumes and the availability of in-house diagnostic and therapeutic services. These institutions play a critical role in the adoption and use of ERCP procedures, contributing significantly to market growth.
By Application:
Pancreatic sphincterotomy is expected to maintain a leading position, owing to the rising incidence of bile duct and pancreatic duct stones. Additionally, the increasing geriatric population in North America, which is prone to biliary disorders, further supports the demand for ERCP procedures.
For comprehensive insights, visit: Explore the Study@https://www.stellarmr.com/report/req_sample/North-America-Endoscopic-Retrograde-Cholangiopancreatography-Market/709
Key Players in the North American ERCP Market
- Hobbs Medical Inc. (US)
- Steris PLC (US)
- Merit Medical Systems, Inc. (US)
- TeleMed Systems, Inc. (US)
- Kimberly-Clark Corporation (US)
- Boston Scientific Corporation (US)
- Olympus Corporation (US)
- Medtronic (US)
- Ambu Inc. (US)
- Conmed Corp (US)
These companies are actively engaged in developing and supplying advanced ERCP solutions, positioning themselves to meet the rising healthcare demands across North America.
For exclusive insights, follow this link: Detailed Study
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2022)
- Past Pricing and price curve by region (2018 to 2022)
- Market Size, Share, Size & Forecast by Different Segment | 2024-2030
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of Business by Region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Trending Reports:
Asia Pacific Digital Power Utility Market https://www.stellarmr.com/report/APAC-Digital-Power-Utility-Market/1285
Asia Pacific Electric Substation Market https://www.stellarmr.com/report/Asia-Pacific-Electric-Substation-Market/1286
Asia Pacific Electrical Conduit Market https://www.stellarmr.com/report/Asia-Pacific-Electrical-Conduit-Market/1287
About Stellar Market Research:
Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Stellar Market Research:
S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud, Pune,
Pune, Maharashtra, 411029
